Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Clodi, M; Abrahamian, HE; Drexel, H; Fasching, P; Hoppichler, F; Kautzky-Willer, A; Lechleitner, M; Ludvik, B; Prager, R; Roden, M; Saely, C; Schernthaner, G; Schober, E; Toplak, H; Wascher, T; Weitgasser, R.
Antihyperglycemic Treatment Guidelines for diabetes mellitus type 2].
Wien Klin Wochenschr. 2012; 124 Suppl 2(4):10-16
Doi: 10.1007/s00508-012-0263-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Toplak Hermann
- Wascher Thomas
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Hyperglycemia significantly contributes to micro- and macrovascular complications in patients with diabetes mellitus. While lifestyle interventions remain cornerstones of disease prevention and treatment, most patients with type 2 diabetes will eventually require pharmacotherapy for glycemic control. The definition of individual targets in regard of optimal therapeutic efficacy and high therapeutic safety is of great importance. In this guideline we present the best and most current evidence-based clinical practice data for healthcare professionals.
- Find related publications in this database (using NLM MeSH Indexing)
- -
- Diabetes Mellitus, Type 2 - drug therapy
- Humans -
- Hyperglycemia - drug therapy
- Hypoglycemic Agents - administration & dosage
- Internationality -
- Practice Guidelines as Topic -